相关实验视频

Updated: Oct 9, 2026

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

偶然的甲状腺癌:与头癌的手术相关的经验

Pingdong Li^1,2, Xiaolian Fang^1,2, Zheng Yang^1,2

¹Department of Otolaryngology, Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China.

|June 7, 2023

概括

在头部和部手术期间发现的偶然甲状腺癌 (ITC) 需要注意. 在这些罕见的甲状腺癌病例中,建议进行术后的TSH抑制疗法和随访.

科学领域:

在瘤学瘤学.
头部和部手术头部和部手术
内分泌学在内分泌学.

背景情况:

偶然的甲状腺癌 (ITC) 是头癌手术中罕见的发现.
目前对ITCs在这种情况下的治疗指南缺乏.
本研究回顾了与头癌手术相关的ITC的机构经验.

研究的目的:

描述在头癌手术期间发现的偶然甲状腺癌 (ITC) 的治疗方法和结果.
为在接受重大头部和部手术的患者中管理ITC提供见解.

主要方法:

在5年内对11名ITC患者进行头手术的回顾性分析.
收集的数据包括结节的特征,病理,手术程序和随访.
所有患者都接受了甲状腺刺激激素 (TSH) 抑制疗法,并被跟踪超过1年.

主要成果:

确定了11名患有ITC的患者 (10名男性,1名女性;平均年龄58岁).
大多数患者 (72.7%) 患有喉状细胞癌;7人患有手术前的甲状腺结节.
在TSH抑制治疗后,没有观察到甲状腺癌的复发或死亡.

结论:

头部手术患者的偶然甲状腺癌需要更多的临床关注.
为了更好地理解和管理,需要进一步的研究和长期跟进.
推在手术前用细针吸收 (FNA) 检查可疑结节;术后适用于TSH抑制和随访.

关键词:

头癌是头部和部的癌症.偶然发生的甲状腺癌.皮囊甲状腺癌皮囊甲状腺癌预后预后预后

更多相关视频

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Published on: May 12, 2023

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma

Published on: September 15, 2023

相关概念视频

Hyperthyroidism I: Introduction

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...

Hyperthyroidism II: Pathophysiology

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...

Graves' Disease I: Introduction

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...